comprehensive -WSS

comprehensive

author：focus 2025-09-29 22:38:23 - browse：67322

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： H5N1 bird flu virus started spreading in cows in Texas in December

WSS

A $475,000 price tag for a new cancer drug: crazy or meh?

Close Medicare's dangerous gaps in addiction treatment coverage

Orangutan used medicinal plant to treat wound, first time ever seen

Dogs on Prozac: What pet anti

The real point of Kenneth Smith’s execution by nitrogen gas

Orangutan used medicinal plant to treat wound, first time ever seen

entertainment

comprehensive

focus

Novavax promises a turnaround & Lilly roils the obesity market

Close Medicare's dangerous gaps in addiction treatment coverage

New air purifier tech could be key to improving indoor air quality

Why rehabilitation engineers need to center patients in their research

Drug repurposing or repositioning? The language matters

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Activists slam private health insurers over coverage restrictions

Key Senate committee drafts bipartisan bill to stem drug shortages

United colonoscopy coverage change 'may cost lives,' doctors say

A $475,000 price tag for a new cancer drug: crazy or meh?

Wikipedia

FDA drug safety: Singulair case shows systemic surveillance flaws

Element Biosciences CEO lays out genome sequencing strategy

Time to name cancers by genetics, not organ of origin, expert says

Bird flu outbreak in cows is latest avian flu curveball

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Orangutan used medicinal plant to treat wound, first time ever seen

knowledge

Wikipedia

leisure time

leisure time